CDNA Competitors & Alternatives
Compare CareDx Inc with similar stocks in the same industry
Diagnostics & Research
CDNA
Main Stock$66.23
Tradestie Score
32
Market Cap
$798.40M
P/E Ratio
30.8
Revenue Growth
0.5%
Analyst Upside
-11.2%
Top Competitors
35 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BLLN
BLLN
|
$105.76
|
$5.02B | 149.9 | 35 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$18.12
|
$4.60B | 32.4 | 54 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$70.96
|
$3.26B | - | 57 | Compare |
|
VCYT
Veracyte, Inc.
|
$44.19
|
$2.85B | 32.9 | 37 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$132.56
|
$2.24B | - | 34 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$27.37
|
$2.22B | - | 49 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$188.05
|
$1.77B | - | 48 | Compare |
|
NEOG
Neogen Corp
|
$12.24
|
$1.26B | - | 49 | Compare |
|
OPK
Opko Health Inc.
|
$1.57
|
$1.23B | - | 46 | Compare |
|
NEO
NeoGenomics, Inc.
|
$17.78
|
$1.13B | - | 33 | Compare |
More CDNA Analysis
Data updated: Oct 01, 2026 | Industry: Diagnostics & Research (SIC 8071)
35 stocks in this industry